Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) EBIT (2024 - 2025)

Profound Medical (PROF) has 2 years of EBIT data on record, last reported at $27.5 million in Q4 2025.

  • For Q4 2025, EBIT rose 429.98% year-over-year to $27.5 million; the TTM value through Dec 2025 reached -$6.3 million, up 80.8%, while the annual FY2025 figure was -$6.3 million, 80.8% up from the prior year.
  • EBIT reached $27.5 million in Q4 2025 per PROF's latest filing, up from -$8.9 million in the prior quarter.
  • Across five years, EBIT topped out at $27.5 million in Q4 2025 and bottomed at -$13.8 million in Q2 2025.